Industry News
Pharmaceutical Industry News
The company is working with…
The company is working with regulators to ensure stable ongoing supply for the one-time gene therapy, it said in a community letter.
Still basking in the afterglow of…
Still basking in the afterglow of its Wegovy pill launch earlier this year, Novo has achieved another victory as it strives to make the most out of its blockbuster GLP-1 drug in an increasingly pressured
Collegium Pharmaceutical will pay…
Collegium Pharmaceutical will pay $650 million upfront to acquire ADHD drug Azstarys from Corium Therapeutics. The deal, which includes an additional $135 million in potential milestone payments, gives Collegium a second branded ADHD treatment, Azstarys, along
A new bill introduced in the…
A new bill introduced in the Maryland House of Delegates requests that pharmas be more specific about the brands related to their otherwise unbranded disease awareness initiatives.
Lynavoy is now the first…
Lynavoy is now the first FDA-approved product that can treat cholestatic pruritus in patients with primary biliary cholangitis.
As part of its $15 billion…
As part of its $15 billion investment commitment in China, AstraZeneca on Thursday unveiled plans to build a commercial cell therapy manufacturing base and an innovation center dedicated to the modality in Shanghai.
The New Alzheimer’s Blood Tests: What to Know
The tests could help to improve dementia care, but scientists say there are still some caveats and unknowns.
Axplora, a German CDMO that…
Axplora, a German CDMO that specializes in specialty active pharmaceutical ingredients for small molecules and antibody-drug conjugates, will shell out $60 million to expand its Farmabios manufacturing facility in Gropello Cairoli, Italy.
After an FDA snub in a broader…
After an FDA snub in a broader metastatic castration-resistant prostate cancer population, Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 readout in metastatic hormone-sensitive prostate cancer.
Since investment bank HSBC…
Since investment bank HSBC downgraded the stock of Eli Lilly from “hold” to “reduce” on Tuesday morning, the share price of the Indianapolis drugmaker has dropped by more than 7%. Creating the stir was a
According to a review by The New…
According to a review by The New York Times, the MFN prices offered on certain drugs through the government's TrumpRx platform may still be higher than those of other countries.
The once-daily pill stands to…
The once-daily pill stands to shake up the injectable-filled psoriasis market and is in line for blockbuster-level sales.
Bristol Myers Squibb has added a…
Bristol Myers Squibb has added a familiar face to an ongoing initiative to thank oncologists for the valuable time they return to cancer patients’ lives.
Sandoz has struck a deal with…
Sandoz has struck a deal with Samsung Bioepis to commercialize up to five biosimilars, with the first being SB36, a copycat of Takeda’s Entyvio, which is being developed by the South Korea-based biosimilars specialist.
Bill Gates-founded TerraPower…
Bill Gates-founded TerraPower Isotopes—which produces actinium-225 derived from legacy U.S. nuclear material—is laying out nearly half a billion dollars as it seeks to become the “premier global distributor” of the rare and promising ingredient.
How TrumpRx Drug Prices Compare With Those in Other Countries
The TrumpRx website claims to offer the best prices for medications. Here’s where Americans still pay more — and much more.
It’s Cruel to Take Away People’s H.I.V. Medication
States are rolling back coverage for lifesaving medications.
Indiana’s governor Mike Braun aims…
Indiana's governor Mike Braun aims to create 100,000 "high wage" jobs over the next decade through the plan, with hopes of transforming the state into the "premier destination" for life sciences innovation.
More than 20 years after gaining…
More than 20 years after gaining FDA approval for Flovent, GSK still controlled the market in the U.S. for the asthma inhaler through a partnership with an “authorized generic” dealer, according to a report released by
It’s time once again for Fierce…
It’s time once again for Fierce Pharma Marketing’s annual #FierceMadness tournament. This time around, we're watching 64 newly minted drug names go head to head.